Yahoo · Sep 17, 2026
Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks
Fed hikes rates and signals another, putting MGEE, ADM, DOLE and DGX in focus as low-beta defensive picks.
NYSE · DGX
Quest Diagnostics Incorporated
Healthcare · Medical - Diagnostics & Research
$246.45
Down-$0.97 (-0.39%)
Updated Sep 20, 2026, 7:36 PM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 20.28B
- P/E ratio
- 20.98
- Dividend yield
- 1.60%
- 52-week range
- $171.18 – $248.70
- Volume
- 1.93M
- Avg. volume
- 1.05M
Price performance
DGX price history
1M range · 19 trading sessions · Daily adjusted prices
DGX closed at $246.45 after 19 trading sessions, up 1.06% for the selected period.
- Last close
- $246.45
- Period change
- +1.06%
- Period low
- $231.14
- Period high
- $247.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $246.52 | $247.625 | $244.89 | $246.45 | 1.93M |
| Sep 17, 2026 | $248.28 | $248.695 | $246.26 | $247.45 | 989.5K |
| Sep 16, 2026 | $245.47 | $248.57 | $244.85 | $247.08 | 948.75K |
| Sep 15, 2026 | $238.39 | $248.65 | $237.21 | $247.08 | 1.37M |
| Sep 14, 2026 | $237.49 | $239.78 | $234.67 | $237.89 | 974.85K |
| Sep 11, 2026 | $233.20 | $235.12 | $229.33 | $235.02 | 997.03K |
| Sep 10, 2026 | $236.32 | $236.475 | $228.57 | $231.14 | 1.09M |
| Sep 9, 2026 | $233.58 | $236.24 | $232.43 | $235.46 | 791.15K |
| Sep 8, 2026 | $233.61 | $237.555 | $231.524 | $235.50 | 728.94K |
| Sep 4, 2026 | $235.38 | $238.915 | $235.38 | $237.14 | 798.7K |
| Sep 3, 2026 | $242.00 | $242.00 | $236.35 | $239.40 | 1.04M |
| Sep 2, 2026 | $238.03 | $242.835 | $236.27 | $240.80 | 1.14M |
| Sep 1, 2026 | $242.72 | $243.72 | $235.625 | $236.22 | 813.39K |
| Aug 31, 2026 | $241.99 | $242.635 | $239.40 | $240.30 | 1.36M |
| Aug 28, 2026 | $245.17 | $245.28 | $242.27 | $242.76 | 639.94K |
| Aug 27, 2026 | $242.83 | $247.19 | $242.44 | $244.61 | 839.99K |
| Aug 26, 2026 | $244.11 | $246.00 | $243.485 | $245.00 | 811.02K |
| Aug 25, 2026 | $243.93 | $245.78 | $241.79 | $244.51 | 709.15K |
| Aug 24, 2026 | $243.97 | $246.00 | $242.455 | $243.87 | 837.74K |
Latest DGX news
The latest Smart Investors Daily articles mentioning DGX.
Stock researchCompany · Overview
DGX research
Overview
Company profile and research snapshot.
Company profile
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $201.60
- Implied upside
- —
- Analysts
- 24
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 8, 2026 | UBS | Neutral | — |
| Jul 28, 2026 | JP Morgan | Neutral | — |
| Jul 24, 2026 | Barclays | Overweight | — |
| Jul 24, 2026 | Baird | Neutral | — |
| Jul 24, 2026 | Truist Securities | Hold | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 16, 2026
Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
A new national survey finds the overwhelming majority of American voters rely on diagnostic laboratory testing to guide their healthcare decisions and are deeply concerned about scheduled Medicare payment cuts that could put that access at risk.
SeekingAlpha · Sep 15, 2026
Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript
Quest Diagnostics Incorporated (DGX) 2026 Global Healthcare Conference September 15, 2026 10:50 AM EDTCompany ParticipantsJames Davis - Chairman, CEO &...
SeekingAlpha · Sep 14, 2026
Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Quest Diagnostics Incorporated (DGX) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:00 AM EDTCompany ParticipantsSam Samad -...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
